Syndax Pharmaceuticals, Inc. (SNDX)

Syndax Pharmaceuticals Stock Forecast

Stock Price Forecast

The 13 analysts that cover Syndax Pharmaceuticals stock have a consensus rating of "Strong Buy" and an average price target of $38.69, which forecasts a 57.02% increase in the stock price over the next year. The lowest target is $17 and the highest is $57.

Price Target: $38.69 (+57.02%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$17	$38.69	$40	$57
Change	-31.01%	+57.02%	+62.34%	+131.33%

Analyst Ratings

The average analyst rating for Syndax Pharmaceuticals stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Nov '25	Dec '25	Jan '26	Feb '26	Mar '26	Apr '26
Strong Buy	8	8	8	8	8	8
Buy	3	3	3	3	4	4
Hold	1	1	1	1	1	1
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	12	12	12	12	13	13

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Corinne Johnson Goldman Sachs	Goldman Sachs	Strong Buy Maintains $28 → $34	Strong Buy	Maintains	$28 → $34	+37.99%	Apr 1, 2026
Salim Syed Mizuho	Mizuho	Buy Maintains $45 → $43	Buy	Maintains	$45 → $43	+74.51%	Mar 31, 2026
Faisal Khurshid Jefferies	Jefferies	Strong Buy Initiates $48 → $40	Strong Buy	Initiates	$48 → $40	+62.34%	Mar 30, 2026
Anupam Rama JP Morgan	JP Morgan	Buy Maintains $33 → $45	Buy	Maintains	$33 → $45	+82.63%	Mar 9, 2026
Yigal Nochomovitz Citigroup	Citigroup	Strong Buy Maintains $51 → $57	Strong Buy	Maintains	$51 → $57	+131.33%	Mar 2, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

357.45M

Increased by 107.40%

from 172.35M

Revenue Next Year

512.15M

Increased by 43.28%

from 357.45M

EPS This Year

-1.58

from -3.29

EPS Next Year

-0.22

from -1.58

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	139.71M	-	-	23.68M	172.35M	357.45M	512.15M
Revenue Growth	9,109.56%	-	-	-	627.84%	107.40%	43.28%
EPS	0.46	-2.46	-2.98	-3.72	-3.29	-1.58	-0.22
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	16	15

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027	2028	2029	2030
High	453.7M	705.3M
Avg	357.5M	512.2M
Low	227.4M	293.0M

Revenue Growth

Revenue Growth	2026	2027	2028	2029	2030
High	163.2%	97.3%
Avg	107.4%	43.3%
Low	31.9%	-18.0%

EPS Forecast

EPS	2026	2027	2028	2029	2030
High	-0.55	1.48
Avg	-1.58	-0.22
Low	-2.65	-1.96

EPS Growth

EPS Growth	2026	2027	2028	2029	2030
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.